Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of obatoclax mesylate (GX15-070MS) in hematological malignancies has completed. The update discusses safety and preliminary efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Drugs mentioned

• Obatoclax Mesylate (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: Hematological Malignancies | Phase 1 | Status: COMPLETED